|
Apolipoprotein E Genotyping (E2)
|
|
General
|
| |
Clinical Use:
|
Apolipoprotein E (APOE) genotyping is useful in the diagnosis of Type III hyperlipidaemia. The E2 variant in homozygous form is associated with Type III hyperlipidaemia and is characterised by a change in amino acid 158 from arginine to cysteine (R158C).
Please note that E4 status is not reported; this test is inappropriate for Alzheimer's disease. |
| |
Availability:
|
|
| |
Aliases/Synonyms:
| Apo E (E2), APO E Genotyping (E2), ApoE Genotyping (E2), |
| |
Code:
|
BAPOE |
| |
Handling Instructions (to laboratory):
|
Send sample ambient. |
| |
Hyperlink:
|
|
| |
Reference Interval:
|
Refer to report or laboratory
|
Collection Requirements
|
| |
Container:
|
EDTA (LAVENDER), |
| |
Sample Type:
|
See container |
| |
Minimum Collection Volume:
|
|
| |
Collection Instructions:
|
|
Processing Requirements
|
| |
Alternate Containers:
|
|
| |
Processing Instructions:
|
Do not centrifuge sample. |
| |
Minimum Assay Volume:
|
|
| |
Stability:
|
|
| |
Transport Instructions (to testing laboratory):
|
Send sample ambient. |
Testing Locations
|
| |
Performed at:
|
|
Section
|
Department
|
Site
|
Contact Phone
|
| Cardiovascular Genetics |
Biochemistry |
Fiona Stanley Hospital |
6152 8128 |
|
Last Updated : 16-01-2024 11:00 |